Lymphangioleiomyomatosis (LAM) is a rare metastatic cystic lung disease due to a mutation in a TSC tumor suppressor, resulting in hyperactive mTOR growth pathways. The gene discussed is MTOR; the disease is lymphangioleiomyomatosis.